Editorial: A proposal to correct minority underrepresentation in clinical trials

(University of Kentucky) In an editorial in CNS Spectrums, a neurologists takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS) and proposes changes to the system.